Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Affiris initiates preclinical development of Parkinson's vaccine PD-01

Dec. 16, 2008

SkyePharma and Somnus successfully complete phase I trial of SKP-1041 for sleep maintenance

Dec. 16, 2008

Phase III data show paliperidone's efficacy and tolerability in schizophrenia

Dec. 16, 2008

Pharmacokinetic data for retigabine therapy disclosed

Dec. 16, 2008

FDA approves Lusedra for sedation in diagnostic or therapeutic procedures

Dec. 15, 2008

Alexza reports positive results from phase III clinical trial of AZ-004 in bipolar disorder

Dec. 15, 2008

KAI-1678 enters phase IIa trials for the treatment of pain

Dec. 15, 2008

Clinical results disclosed for a novel inhibitor of sodium and calcium channels in epilepsy

Dec. 15, 2008

Javelin reports results from phase III efficacy study of Dyloject in postsurgical pain

Dec. 15, 2008

ITI presents development update of ITI-111 for acute repetitive seizure in epilepsy

Dec. 15, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...